Thymidine kinase activity (TKa) as independent predictor of outcome in metastatic breast cancer (MBC) patients in the GEICAM/2013-02 PEARL trial.


Por: Guerrero, A, Gil, MJG, Williams, A, Ruiz, M, Ritzen, HS, Ciruelos, EM, Munoz, M, Bermejo, B, Margeli, M, Anton, A, Kahan, Z, Csoszi, T, Murillo, L, Murillo, SM, Lang, IS, Herranz, J, Caballero, R, Fisker, H, Portela, M and Martin, M

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Inst Valenciano Oncol IVO, GEICAM Spanish Breast Canc Grp, Valencia, Spain
Inst Catala Oncol ICO, Lhospitalet De Llobregat 08907, Spain
IDIBELL, GEICAM Spanish Breast Canc Grp, Lhospitalet De Llobregat, Spain
Biovica Int AB, Uppsala, Sweden
Hosp Virgen Rocio, GEICAM Breast Canc Grp, Seville, Spain
Hosp Univ 12 Octubre, Madrid, Spain
Hosp Clin Barcelona, GEICAM Spanish Breast Canc Grp, Barcelona, Spain
CIBERONC ISCIII, Hosp Clin Univ Valencia, GEICAM Spanish Breast Canc Grp, Valencia, Spain
Hosp Badalona Germans Trias & Pujol, Catalan Inst Oncol Badalona, B ARGO Grp, Badalona, Barcelona, Spain
GEICAM Spanish Breast Canc Grp, Barcelona, Spain
Univ Zaragoza, Hosp Univ Miguel Servet, Inst Invest Sanitaria Aragon, GEICAM Spanish Breast Canc Grp, Zaragoza, Spain
Univ Szeged, Dept Oncotherapy, CECOG, Szeged, Hungary
Jasz Nagykun Szolnok Cty Hosp, Oncol Dept, Szolnok, Hungary
Hosp Clin Univ Lozano Blesa, GEICAM Spanish Breast Canc Grp, Zaragoza, Spain
Hosp Arnau Vilanova, Lleida, Spain
GEICAM Spanish Breast Canc Grp, Lleida, Spain
Istenhegy Gendiagnosztika Private Hlth Ctr Oncol C, Budapest, Hungary
GEICAM Spanish Breast Canc Grp, Madrid, Spain
Univ Complutense Madrid, Inst Invest Sanitaria Gregorio Maranon, GEICAM Breast Canc Grp, CIBERONC, Madrid, Spain
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas: 1066-1066
WOS Id: 001509511000001
imagen Green Submitted, Bronze

MÉTRICAS